Head-to-head · computed 2026-08-11
Direct Meds vs Hims & Hers
Direct Meds: Direct Meds offers compounded GLP-1s in multiple formats — sublingual and injectable — with all-inclusive pricing verified on its own product pages. Semaglutide runs $249–$297/mo and tirzepatide $299–$399/mo depending on format; the lower figures are for sublingual delivery. Hims & Hers: After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound $399/month, on top of a $149/month membership ($39 first month) plus $5 shipping.
Tirzepatide
| Direct Meds | Hims & Hers | |
|---|---|---|
| All-in maintenance | $399/mo | $548/mo |
| Best plan rate | $399/mo | $548/mo |
| 12-month total | $4,788 | $6,576 |
| Status | Reported · 2026-07-25 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Direct Meds's $399 a month undercuts Hims & Hers's $548 by $149 a month at the 10 mg/wk maintenance basis — $1,788 across a year. Direct Meds's figure is reported (captured 2026-07-25) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Direct Meds's tirzepatide ladder runs $399 a month billed monthly. Hims & Hers's runs $548 a month billed monthly. On the twelve-month basis Direct Meds's $4,788 beats Hims & Hers's $6,576 by $1,788 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| Direct Meds | Hims & Hers | |
|---|---|---|
| All-in maintenance | $297/mo | $453/mo |
| Best plan rate | $297/mo | $453/mo |
| 12-month total | $3,564 | $5,436 |
| Status | Reported · 2026-07-25 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Direct Meds's $297 a month undercuts Hims & Hers's $453 by $156 a month at the 2.4 mg/wk maintenance basis — $1,872 across a year. Direct Meds's figure is reported (captured 2026-07-25) and Hims & Hers's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Direct Meds's semaglutide ladder runs $297 a month billed monthly. Hims & Hers's runs $453 a month billed monthly. On the twelve-month basis Direct Meds's $3,564 beats Hims & Hers's $5,436 by $1,872 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Where the structures genuinely differ
Direct Meds carries no membership fee against Hims & Hers's $149 a month — $1,788 a year of structural cost before any medication ships, which is why this site prices everything all-in.
Structure, side by side
Direct Meds
- MembershipNone
- Dose policyAll-inclusive per format; injection and sublingual priced separately
- CommitmentMonthly (no commitment indicated)
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
Hims & Hers
- Membership$149/mo
- Dose policyBrand list pricing by product
- CommitmentMembership month-to-month ($39 first month)
- CancellationCancel anytime
- PharmacyBrand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy
What our desk is watching on each
Direct Meds: Pricing varies by format and page; product-page 'all-inclusive' rates differ from homepage promo cards. Rank is based on injectable rate as primary. Reported status — RangeYourself verified 2026-07-25 on Direct Meds' own product pages.
Hims & Hers: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.
Questions people ask
Is Direct Meds or Hims & Hers cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Direct Meds vs Hims & Hers miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Direct Meds and Hims & Hers cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $4,788 at Direct Meds and $6,576 at Hims & Hers — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Direct Meds · Hims & Hers. Official sites: Direct Meds ↗ · Hims & Hers ↗. Nothing here is medical advice.